Dr. Shinji Takamatsu | Virology | Excellence in Research Award

Specially Appointed Researcher | The University of Osaka | Japan

Dr. Takamatsu has built a distinguished research career characterized by sustained scientific excellence and innovative contributions to glycobiology. His achievements are reflected in over 87 peer-reviewed journal publications, multiple patents, and active participation in significant national and international collaborations, including the NEDO industry–academia–government complex carbohydrate consortium. His pioneering research on the inhibitory effects of the PhoSL lectin on HBV infection has advanced the understanding of virus–host interactions and informed new therapeutic strategies. In addition to his scientific output, he maintains membership in leading professional organizations such as the Society for Glycobiology, the Japanese Society of Carbohydrate Research, and the Japanese Cancer Association, underscoring his recognition within the global research community. Across decades of research, his work has made meaningful contributions to hepatology, immunology, and cancer therapy, demonstrating a consistent record of innovation, translational impact, and scientific leadership.

Profiles: Scopus | ORCID

Featured Publications

Takamatsu, S., et al. (1996). Glycan-mediated immune regulation mechanisms. Journal of Immunology.

Takamatsu, S., et al. (2018). Lectin-based inhibition of viral replication pathways. Journal of Hepatology.

Takamatsu, S., et al. (2020). Core-fucose-specific PhoSL inhibits HBV infection in human hepatocytes. Glycobiology.

Takamatsu, S., et al. (2022). Glycan signatures in digestive disease progression. Carbohydrate Research.